How BioCryst Pharmaceuticals, Inc. stacks up

BCRX · against 454 other Healthcare companies listed in US-listed

Growth

89/ 100

Near the top of its peers.

Ranked #86 of 455 · scores higher than 80% of peers

Bars: peers in each 10-point band of the growth score

66 peers with a growth score of 80–89, including BCRX · Click a bar to see the companies

Why growth scores 89?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.

The loss per share widened. Earnings per share growth: — vs peer median 9.8%
faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 45.3% vs peer median 5.8%
faster revenue growth over the last year: stronger than 92% of peers. Revenue growth: 68.7% vs peer median 6.1%

Metric by metric

Position: dot = BCRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	BCRX	Peer median	Better than	Position among peers	Weight
Revenue growthHigher is better · 475 reported	68.7%	11.0%	86%		33%
Earnings per share growthHigher is better · 171 reported	Not reported	21.2%	—	—	33%
3-year revenue growthHigher is better · 433 reported	45.3%	11.0%	84%		33%

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by growth score

Top 5 and the companies ranked around BCRX

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
79	Vericel CorporationVCEL · US-listed	2.1B USD	90	61
86	Amneal Pharmaceuticals, Inc.AMRX · US-listed	7.0B USD	89	57
86	ANI Pharmaceuticals, Inc.ANIP · US-listed	1.7B USD	89	77
86	Astrana Health, Inc.ASTH · US-listed	1.8B USD	89	52
86	BioCryst Pharmaceuticals, Inc.BCRX · US-listed	2.2B USD	89	32
86	BrightSpring Health Services, Inc.BTSG · US-listed	13.8B USD	89	54
91	Ardelyx, Inc.ARDX · US-listed	782M USD	88	35
91	Indivior Pharmaceuticals, Inc.INDV · US-listed	4.3B USD	88	69
91	LENZ Therapeutics, Inc.LENZ · US-listed	110M USD	88	54

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…